Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.
about
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesHow to manage warfarin therapyPredicting the risk of venous thromboembolism recurrenceEffect of access to anticoagulation management services on warfarin use in patients with atrial fibrillationOptimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care settingPatient and physician satisfaction with a telephone-based anticoagulation serviceOutpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.A test of financial incentives to improve warfarin adherenceLong term oral anticoagulant therapy with warfarin: experience with local patient population in kuwait.Warfarin therapy: in need of improvement after all these years.Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Ambulatory care pharmacy services: has the agenda changed?Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinicAdequacy of anticoagulation in patients with atrial fibrillation coming to a hospital.Clinical pharmacy in disease-specific clinics.Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice.Improving outpatient warfarin use for hospitalized patients with atrial fibrillationOral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Hospital nurses' perceptions of pharmacist prescribing.A survey of physicians' knowledge and management of venous thromboembolism.Weekend versus weekday admission and mortality after acute pulmonary embolism.Racial differences in primary care opioid risk reduction strategiesOutcome of left heart mechanical valve replacement in West African children--a 15-year retrospective study.Evidence of the economic benefit of clinical pharmacy services: 1996-2000.Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness.Collaborative drug therapy management: case studies of three community-based models of care.A primer for developing pharmacist-managed clinics in the outpatient setting.A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trialA systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.Health literacy and anticoagulation-related outcomes among patients taking warfarin.Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.A strategy to develop advanced pharmacy practice experiences.Costs and clinical consequences of suboptimal atrial fibrillation management.Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists.Initiating warfarin therapy: 5 mg versus 10 mg.Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin.Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis.
P2860
Q24632951-3BC7470B-B96A-46D3-B8CE-D48F14A4E992Q26773328-4386A7AF-49C7-4DEE-83FA-7F3BE8DF35C3Q26865059-C6DF58CA-2893-493F-8F31-1F34FA32A1C4Q28192385-04B2C60A-7615-4593-ACDF-E6FBEA2E715CQ28193213-22FAC3A0-6466-44B2-A0AB-CCBABDD27863Q28346620-C69C6793-9E47-46D5-9432-0AD6513F81AFQ33311569-DDE4D394-F4F5-4305-B955-096CDDF251F6Q33395146-EA581375-55D6-45F3-B804-5E5D5271D763Q33619662-1BEEF7CF-3C76-4D02-8ED1-5C4C94651CF7Q33793086-58B41A32-D9C3-45DF-AE7C-5635480E82A7Q33815844-1A8ACFF1-70B4-4957-83CA-B47BC40034F7Q33891646-CFC2C117-F2A1-4FB0-B290-5E6F41C120D6Q33946534-93EE2DE6-102C-4AB5-ABEF-27598D0D0448Q33995194-7BF49F64-76C2-49A8-8C95-63DDC169106BQ34041367-4CA15899-F912-4B66-8F97-6C035F8F115CQ34061807-717A0515-7183-4A31-B301-F57C9696D3DAQ34093617-6058335F-1AFF-4247-98F4-7D591A15ED75Q34100740-D143B4FF-C251-4D67-BA7F-76B4E5A777EDQ34252907-70C4D04F-AB73-4D5E-9476-DEABEACBEADAQ34778884-9FFA7ECF-D991-44B3-9A3E-8E09B8122117Q34875662-EBCB34B1-D43E-4E51-8AD8-1FA17040B83BQ34940769-F623954A-F97D-440B-B8DB-C88D90635A0CQ34958037-1EAB6270-249E-4083-964D-97911492DDCFQ35023589-F0900E72-9598-49C0-9A06-F6FCBA1973BCQ35043395-507ECF98-22F6-40D7-BB86-98E8B11891BCQ35119855-F088C9B9-F67C-412B-9F19-239C7780A006Q35222704-28B5E9D0-8FFB-4B9C-890A-9F1F2DF7AB2DQ35549767-1DE6EB59-AAA2-41B2-B0B0-F34DFDE3B587Q35586484-5D10662B-5078-47E7-8638-D5CF707F03B9Q35654467-9B8FB572-A78C-4E83-AB81-BB045B9D4595Q35671241-91495FD6-CAF9-42A5-B322-5F3B4111CF8DQ35695836-01C91184-E73F-4910-80F8-81F121F1E1EBQ35827850-C419A5C4-30E3-4F71-BC4E-685F27847251Q35875442-C146208C-424E-4B1D-BF6F-DE18094A3DA7Q35879152-3F7DE497-1354-4386-8E78-E393F6E2E1BDQ35885128-010CE584-EBF9-4974-9803-79EA8A84A867Q35906334-2371234D-9BB1-4971-8BF8-B849E1D56A72Q35937712-B99492D1-56F8-4371-BC9F-BD0E0C495E50Q35997998-F0529F9D-BF6D-468B-AA32-72DB8A575117Q36146313-ECF10E43-FA8A-49C1-8B84-A3DD31C731CE
P2860
Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Comparison of an anticoagulati ...... tcomes, and health care costs.
@en
Comparison of an anticoagulati ...... tcomes, and health care costs.
@nl
type
label
Comparison of an anticoagulati ...... tcomes, and health care costs.
@en
Comparison of an anticoagulati ...... tcomes, and health care costs.
@nl
prefLabel
Comparison of an anticoagulati ...... tcomes, and health care costs.
@en
Comparison of an anticoagulati ...... tcomes, and health care costs.
@nl
P2093
P1476
Comparison of an anticoagulati ...... tcomes, and health care costs.
@en
P2093
P304
P356
10.1001/ARCHINTE.158.15.1641
P407
P577
1998-08-01T00:00:00Z